Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (5): 314-315.
Previous Articles Next Articles
LIU Meng-xing ,CHEN Yong-gang ,LUO Ji ,WANG Jun-long ,SUN Hui ,CHEN Jie
Received:
2017-12-11
Revised:
2018-06-21
Online:
2018-05-20
Published:
2018-06-21
CLC Number:
LIU Meng-xing ,CHEN Yong-gang ,LUO Ji ,WANG Jun-long ,SUN Hui ,CHEN Jie. One Case of Severe Erythema Multiforme Drug Eruption Accompanied by Drug-induced Liver Injury Induced by Wikstroemiae indicae Radix Tablets [J]. Chinese Journal of Pharmacovigilance, 2018, 15(5): 314-315.
Add to citation manager EndNote|Ris|BibTeX
[1] 南京中医药大学.中药大辞典[M].2版.上海:上海科学技术出版社, 2006:68 -71. [2] 张立,喻文进,刘慧琼,等. 西瑞香素抗炎抑菌作用的初步实验研究[J]. 中医药导报,2012,18(6):72-73. [3] 熊友香,尤志勉,程东庆,等. 了哥王不同提取部位抑菌作用研究[J]. 中国中医药信息杂志,2008,15(10):42-43. [4] 薛 一. 了哥王细胞毒性和抗病毒活性成分研究[D].暨南大学,2007. [5] 柯雪红,王丽新,黄可儿. 了哥王片抗炎消肿及镇痛作用研究[J]. 时珍国医国药,2003,14(10):603-604. [6] 张鑫. 了哥王的化学成分及镇痛抗炎活性研究[D].广东药学院,2011. [7] 杨振宇,郭薇,吴东媛,等. 了哥王中西瑞香素的提取分离及抗肿瘤作用研究[J]. 天然产物研究与开发,2008,20(3):522-526. [8] 邵萌,黄晓君,孙学刚,等. 了哥王根茎中的酚性成分及其抗肿瘤活性研究[J]. 天然产物研究与开发,2014,26(6):851-855,875. [9] 李雨田,顾雪竹,张村. 了哥王的化学成分和药理作用研究进展[J]. 中国实验方剂学杂志,2011,17(24):252-255. [10] 赵华亮. 了哥王致红斑疹1例[J]. 中国药物滥用防治杂志,2007,13(1):55. [11] 李明桂. 中药了哥王致眼角膜灼伤1例[J]. 中国中医眼科杂志,1999,9(2):50. [12] 王志中.了哥王引起过敏性休克一例[J]. 河南赤脚医生,1981,(4):30. [13] 张庆文,余奕明,曾力生,等. 口服了哥王中毒致死1例[J]. 中国法医学杂志,2008,23(5):353. [14] 包振宇,邹先彪. 重症药疹的研究进展[J]. 实用皮肤病学杂志,2015,8(2):112-114,118. [15] 郭秀芝. 中草药过敏及毒性反应机理[J]. 山东医药工业,1998,17(5):50-51. [16] 林明宝. 中药引发过敏反应的危险因素及中成药致敏成分研究[D].浙江大学,2013. [17] 佟立今,孙立新,孙丽霞,等. 了哥王化学成分的分离与鉴定[J]. 中国药物化学杂志,2015,25(1):50-53. [18] 邵萌,黄晓君,孙学刚,等. 了哥王根茎中的酚性成分及其抗肿瘤活性研究[J]. 天然产物研究与开发,2014,26(6):851-855,875. [19] 易文燕,刘明,陈敏,等. 了哥王化学成分研究[J]. 时珍国医国药,2012,23(12):3001-3003. [20] 么焕开,仲英,尹俊亭. 了哥王的化学成分研究(Ⅰ)[J]. 中草药,2007,38(5):669-670. [21] 张金娟,熊英,张贵林,等. 了哥王提取物及其不同提取部位的急性毒性研究[J]. 时珍国医国药,2011,22(11):2829-2830. [22] 冯果,李玮,何新,等. 苗族药了哥王不同提取物对正常大鼠肝毒性的影响[J]. 中国实验方剂学杂志,2017,23(11):96-102. [23] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南(2015版)[J].中华肝脏病杂志,2015,23(11):810-820. [24] Martinez M A, Vuppalanchi R, Fontana R J, et al. Clinical and histologic features of azithromycin-induced liver injury[J].Clin Gastroenterol Hepatol, 2015, 13(2):369-376. |
[1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
[2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
[3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
[4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
[5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
[6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
[7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
[8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
[9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
[10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
[11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
[12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
[13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
[14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
[15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||